Clinical Study

Two-Year Accelerated Corneal Cross-Linking Outcome in Patients with Progressive Keratoconus

Table 1

Clinical parameters in qualifying examination and control tests at 7 days, 14 days, and 3, 12, and 24 months after accelerated cross-linking in patients with progressive keratoconus.

Pre-CXL (range)7 days (range) value pre-CXL, 7 days14 days (range) value pre-CXL, 14 days3 months (range) value pre-CXL, 3 months12 months (range) value pre-CXL, 12 months24 months (range) value pre-CXL, 24 months

UCVA ()0,24 ± 0,15
(0,05–0,5)
0,07 ± 0,05
(0,004–0,2)
= 0.0000,15 ± 0,1
(0,04–0,3)
= 0.0040,19 ± 0,12
(0,06–0,4)
= 0.0080,23 ± 0,13
(0,06–0,4)
> 0.050,24 ± 0,14
(0,05–0,5)
> 0.05
BSCVA ()0,48 ± 0,2
(0,15–0,8)
0,16 ± 0,15
(0,004–0,6)
= 0.0000,33 ± 0,22
(0,08–0,8)
= 0.0010,45 ± 0,22
(0,1–0,8)
= 0.0430,47 ± 0,19
(0,125–0,8)
> 0.050,48 ± 0,21
(0,125–0,8)
> 0.05
Corneal topographic astigmatism (D)2,16 ± 1,05
(0,9–4,5)
2,19 ± 0,96
(0,3–3,3)
> 0.052,25 ± 1,15
(0,9–4,8)
> 0.052,21 ± 1,12
(0,5–4,3)
> 0.051,91 ± 1,08
(0,5–4,4)
> 0.052,00 ± 1,04
(0,75–4,3)
> 0.05
Sim (D)47,61 ± 2,07
(43,3–51,2)
47,66 ± 2,06
(43,7–50,7)
> 0.0547,51 ± 2,55
(44,0–53,3)
> 0.0547,07 ± 2,41
(43,4–51,5)
> 0.0546,28 ± 3,08
(37,2–49,4)
> 0.0546,96 ± 1,93
(43,5–49,7)
> 0.05
Sim (D)45,39 ± 1,71
(41,7–48,2)
45,14 ± 2,44
(39,7–48,6)
> 0.0545,05 ± 2,78
(39,2–48,5)
> 0.0545,14 ± 2,44
(39,4–48,2)
> 0.0544,64 ± 3,58
(33,5–47,4)
> 0.0545,04 ± 2,3
(39,5–47,1)
> 0.05
Corneal eccentricity index0,82 ± 0,24
(0,26–1,16)
0,79 ± 0,36
(0,03–1,12)
> 0.050,82 ± 0,31
(0,15–1,3)
> 0.050,84 ± 0,24
(0,22–1,17)
> 0.050,82 ± 0,29
(0,01–1,17)
> 0.050,81 ± 0,25
(0,27–1,23)
> 0.05
Pachymetry in central point (μm) in USP509 ± 22
(476–567)
582 ± 41
(525–681)
= 0.000533 ± 49
(470–630)
> 0.05502 ± 26
(458–552)
> 0.05492 ± 23
(446–535)
= 0.001512 ± 28
(476–579)
> 0.05
Pachymetry in apex point (μm) in USP452 ± 28
(412–521)
509 ± 22
(476–567)
< 0.05489 ± 33
(435–560)
> 0.05448 ± 33
(409–537)
> 0.05450 ± 33
(409–535)
> 0.05448 ± 32
(420–530)
> 0.05

BSCVA: best spectacle-corrected visual acuity; CXL: corneal collagen cross-linking; D: diopters; : logarithm of the minimum angle of resolution; pre-: before treatment; Sim : simulated keratometry in the steepest meridian; Sim : simulated keratometry in the flattest meridian; UCVA: uncorrected visual acuity; USP: ultrasound pachymetry; data are mean ± standard deviation.